Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
4 clinical trials · Sponsor
◉ Watch Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia (NCT06949852) | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | 2024-08-07 |
| Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers (NCT06902103) | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | 2023-12-20 |
| Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment (NCT07033182) | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | 2023-10-30 |
| A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria (NCT06828874) | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | 2023-05-10 |
Track Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.